{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:06:22Z","timestamp":1781215582235,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014969","name":"Guilin Medical University","doi-asserted-by":"publisher","award":["2025SRP010"],"award-info":[{"award-number":["2025SRP010"]}],"id":[{"id":"10.13039\/501100014969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SL2024A04J01628"],"award-info":[{"award-number":["SL2024A04J01628"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500659"],"award-info":[{"award-number":["82500659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Provincial Medical Research Foundation","doi-asserted-by":"publisher","award":["A2025179"],"award-info":[{"award-number":["A2025179"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178271","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T14:07:29Z","timestamp":1760796449000},"page":"178271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of four-week rifaximin treatment on abdominal symptoms, psychological state and gut microbiome in diarrhea-predominant irritable bowel syndrome: a pilot study"],"prefix":"10.1016","volume":"1007","author":[{"given":"Gaichao","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejphar.2025.178271_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.32","article-title":"Effects of rifaximin on transit, permeability, fecal microbiome, and organic acid excretion in irritable bowel syndrome","volume":"7","author":"Acosta","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.178271_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/nmo.12811","article-title":"Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea","volume":"28","author":"An","year":"2016","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2050640615581113","article-title":"Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: a cohort study with prospective follow-up","volume":"4","author":"Andresen","year":"2016","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"10.1016\/j.ejphar.2025.178271_bib4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S2468-1253(24)00245-0","article-title":"Personalisation of therapy in irritable bowel syndrome: a hypothesis","volume":"9","author":"Black","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.178271_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-025-01065-9","article-title":"Common misconceptions and controversies in the management of irritable bowel syndrome","volume":"22","author":"Black","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00691-09","article-title":"Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178271_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","article-title":"Irritable bowel syndrome: treatment based on pathophysiology and biomarkers","volume":"72","author":"Camilleri","year":"2023","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ejphar.2025.178271_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat. Methods"},{"issue":"379","key":"10.1016\/j.ejphar.2025.178271_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6397","article-title":"Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice","volume":"9","author":"De Palma","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"Pt 2","key":"10.1016\/j.ejphar.2025.178271_bib10","article-title":"Rifaximin alleviates intestinal barrier disruption and systemic inflammation via the PXR\/NFkappaB\/MLCK pathway and modulates intestinal Lachnospiraceae abundance in heat-stroke mice","volume":"143","author":"Du","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.178271_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1160069","article-title":"Deciphering the mechanism of jujube vinegar on hyperlipoidemia through gut microbiome based on 16S rRNA, BugBase analysis, and the stamp analysis of KEEG","volume":"10","author":"Duan","year":"2023","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178271_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/AAC.00688-10","article-title":"In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile","volume":"55","author":"Farrell","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2018.1460013","article-title":"Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome","volume":"10","author":"Fodor","year":"2019","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.ejphar.2025.178271_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ibd.21035","article-title":"Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity","volume":"16","author":"Hong","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2429029","article-title":"Rifaximin alleviates irinotecan-induced diarrhea in mice model","volume":"56","author":"Huang","year":"2024","journal-title":"Ann. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178271_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11306-022-01900-z","article-title":"Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS)","volume":"18","author":"Karpe","year":"2022","journal-title":"Metabolomics"},{"issue":"9","key":"10.1016\/j.ejphar.2025.178271_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/19490976.2017.1361091","article-title":"Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period","volume":"9","author":"Lashermes","year":"2018","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178271_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-025-07962-w","article-title":"FGF15\/FGFR4 signaling suppresses M1 macrophage polarization and multi-organ inflammation in septic mice by inhibiting H3K18 lactylation-driven Irf7 expression through NF2-Hippo activation","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12934-021-01720-1","article-title":"The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors","volume":"20","author":"Lin","year":"2021","journal-title":"Microb. Cell Fact."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178271_bib23","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1093\/ibd\/izab293","article-title":"Pseudomembranous colitis caused by Haemophilus Parainfluenzae","volume":"28","author":"Liu","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178271_bib24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40168-024-01873-2","article-title":"Microbial assimilatory sulfate reduction-mediated H(2)S: an overlooked role in Crohn's disease development","volume":"12","author":"Luo","year":"2024","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178271_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","article-title":"Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR","volume":"100","author":"Malinen","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178271_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jgh3.12313","article-title":"Microbial dysbiosis in irritable bowel syndrome: a single-center metagenomic study in Saudi Arabia","volume":"4","author":"Masoodi","year":"2020","journal-title":"JGH Open"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2280838","article-title":"Pathogenicity and virulence of Shigella sonnei: a highly drug-resistant pathogen of increasing prevalence","volume":"14","author":"Matanza","year":"2023","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.ejphar.2025.178271_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ueg2.12137","article-title":"Serum L-arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: a nested case-control study","volume":"9","author":"McEvoy","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2025.178271_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-145-8-200610170-00004","article-title":"The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial","volume":"145","author":"Pimentel","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178271_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/j.gastro.2017.05.003","article-title":"Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome","volume":"153","author":"Pinto-Sanchez","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178271_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3920\/BM2019.0171","article-title":"Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment","volume":"11","author":"Ponziani","year":"2020","journal-title":"Benef. Microbes"},{"issue":"11","key":"10.1016\/j.ejphar.2025.178271_bib34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/MEG.0000000000002050","article-title":"Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases","volume":"33","author":"Putignani","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178271_bib35","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.14309\/ajg.0000000000000444","article-title":"Lactulose breath testing as a predictor of response to rifaximin in patients with irritable bowel syndrome with diarrhea","volume":"114","author":"Rezaie","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.178271_bib36","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2584","article-title":"VSEARCH: a versatile open source tool for metagenomics","volume":"4","author":"Rognes","year":"2016","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178271_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2024.02.009","article-title":"Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer","volume":"42","author":"Rosendahl Huber","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178271_bib38","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.178271_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178271_bib40","doi-asserted-by":"crossref","first-page":"G225","DOI":"10.1152\/ajpgi.00091.2013","article-title":"Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response","volume":"305","author":"Singh","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2025.178271_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/CEG.S89999","article-title":"Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach","volume":"8","author":"Soldi","year":"2015","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178271_bib42","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC201706060","article-title":"Irritable bowel syndrome","volume":"166","author":"Sultan","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2025.178271_bib43","first-page":"512","article-title":"Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome","volume":"22","author":"Tana","year":"2010","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","article-title":"Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome","volume":"152","author":"Tap","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejphar.2025.178271_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jand.2019.05.015","article-title":"Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies","volume":"120","author":"Wang","year":"2020","journal-title":"J. Acad. Nutr. Diet."},{"issue":"17","key":"10.1016\/j.ejphar.2025.178271_bib46","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s40265-021-01634-7","article-title":"Diarrhea-predominant and constipation-predominant irritable bowel syndrome: current prescription drug treatment options","volume":"81","author":"Wechsler","year":"2021","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.ejphar.2025.178271_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41579-024-01058-6","article-title":"Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics","volume":"22","author":"Wei","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"issue":"13","key":"10.1016\/j.ejphar.2025.178271_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/nu16132114","article-title":"The efficacy of probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"16","author":"Wu","year":"2024","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178271_bib49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2013.10.026","article-title":"Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats","volume":"146","author":"Xu","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178271_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2263209","article-title":"Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships","volume":"15","author":"Yuan","year":"2023","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.ejphar.2025.178271_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/19490976.2016.1215805","article-title":"Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome","volume":"7","author":"Zeber-Lubecka","year":"2016","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178271_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41420-022-01015-3","article-title":"Overabundance of Veillonella parvula promotes intestinal inflammation by activating macrophages via LPS-TLR4 pathway","volume":"8","author":"Zhan","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.178271_bib53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fcimb.2019.00346","article-title":"Identification of gut Microbiota and metabolites signature in patients with irritable bowel syndrome","volume":"9","author":"Zhu","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejphar.2025.178271_bib54","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3389\/fmicb.2018.01600","article-title":"Fecal microbiota alterations associated with diarrhea-predominant irritable bowel syndrome","volume":"9","author":"Zhuang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178271_bib55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"issue":"11","key":"10.1016\/j.ejphar.2025.178271_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12112376","article-title":"Anthocyanin-rich extract mitigates the contribution of the pathobiont genus haemophilus in mild-to-moderate ulcerative colitis patients","volume":"12","author":"Zobrist","year":"2024","journal-title":"Microorganisms"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:40:02Z","timestamp":1779324002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925010258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"alternative-id":["S0014299925010258"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178271","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of four-week rifaximin treatment on abdominal symptoms, psychological state and gut microbiome in diarrhea-predominant irritable bowel syndrome: a pilot study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178271"}}